Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Convertible Debt (2017 - 2018)

Jaguar Health (JAGX) has disclosed Convertible Debt for 2 consecutive years, with $10.7 million as the latest value for Q3 2018.

  • On a quarterly basis, Convertible Debt fell 4.48% to $10.7 million in Q3 2018 year-over-year; TTM through Sep 2018 was $10.7 million, a 4.48% decrease, with the full-year FY2017 number at $11.0 million, changed N/A from a year prior.
  • Convertible Debt was $10.7 million for Q3 2018 at Jaguar Health, down from $11.0 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $11.2 million in Q3 2017 to a low of $10.7 million in Q3 2018.